Jan Styczyński

11.8k total citations
299 papers, 4.5k citations indexed

About

Jan Styczyński is a scholar working on Oncology, Hematology and Epidemiology. According to data from OpenAlex, Jan Styczyński has authored 299 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Oncology, 90 papers in Hematology and 72 papers in Epidemiology. Recurrent topics in Jan Styczyński's work include Acute Lymphoblastic Leukemia research (70 papers), Hematopoietic Stem Cell Transplantation (55 papers) and Childhood Cancer Survivors' Quality of Life (44 papers). Jan Styczyński is often cited by papers focused on Acute Lymphoblastic Leukemia research (70 papers), Hematopoietic Stem Cell Transplantation (55 papers) and Childhood Cancer Survivors' Quality of Life (44 papers). Jan Styczyński collaborates with scholars based in Poland, Italy and Netherlands. Jan Styczyński's co-authors include Per Ljungman, Rafael de la Cámara, Mariusz Wysocki, Dan Engelhard, Catherine Cordonnier, Simone Cesaro, Lidia Gil, Katherine N. Ward, Nicolaus Kröger and Mohamad Mohty and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Jan Styczyński

257 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Styczyński Poland	31	2.0k	1.7k	1.5k	979	570	299	4.5k
Montserrat Rovira Spain	44	2.1k 1.1×	1.9k 1.1×	2.5k 1.7×	1.1k 1.1×	1.0k 1.8×	218	6.7k
Carlos Solano Spain	35	1.3k 0.7×	1.8k 1.1×	1.6k 1.1×	878 0.9×	840 1.5×	214	4.1k
Jason W. Chien United States	38	1.1k 0.6×	1.5k 0.9×	2.4k 1.6×	870 0.9×	804 1.4×	109	6.0k
Rafael de la Cámara Spain	39	1.9k 1.0×	3.2k 1.9×	1.7k 1.1×	1.6k 1.6×	856 1.5×	154	5.7k
Rafael F. Duarte Spain	39	1.8k 0.9×	1.3k 0.8×	3.3k 2.2×	963 1.0×	1.0k 1.8×	163	6.1k
Finn Bo Petersen United States	33	1.6k 0.8×	1.2k 0.7×	2.9k 1.9×	901 0.9×	932 1.6×	72	5.2k
Sébastien Maury France	31	1.1k 0.6×	795 0.5×	1.8k 1.2×	706 0.7×	1.1k 1.9×	125	3.7k
Carole B. Miller United States	31	1.7k 0.9×	1.0k 0.6×	2.1k 1.4×	1.1k 1.2×	354 0.6×	108	5.2k
Christopher C. Dvorak United States	35	839 0.4×	1.1k 0.7×	1.4k 0.9×	699 0.7×	1.0k 1.8×	173	4.4k
Trudy N. Small United States	37	1.1k 0.6×	1.2k 0.7×	1.6k 1.1×	653 0.7×	1.4k 2.5×	106	3.8k

Countries citing papers authored by Jan Styczyński

Since Specialization

Citations

This map shows the geographic impact of Jan Styczyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Styczyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Styczyński more than expected).

Fields of papers citing papers by Jan Styczyński

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Styczyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Styczyński. The network helps show where Jan Styczyński may publish in the future.

Co-authorship network of co-authors of Jan Styczyński

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Styczyński. A scholar is included among the top collaborators of Jan Styczyński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Styczyński. Jan Styczyński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krawczyk, Małgorzata, Bernarda Kazanowska, Maryna Krawczuk‐Rybak, et al.. (2025). Prognostic Role of Systemic Inflammatory Markers in Pediatric Soft‐Tissue Sarcoma: A Multicenter Study of 213 Patients. Pediatric Blood & Cancer. 72(7). e31701–e31701.

Neofytos, Dionysios, Paul E. Verweij, Diana Averbuch, et al.. (2025). Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee. Current Research in Translational Medicine. 73(3). 103509–103509.

Jabłońska, Anna, et al.. (2025). Next-Generation Sequencing for Infectious Disease Diagnostics in Pediatric Patients with Malignancies or After Hematopoietic Cell Transplantation: A Systematic Review. Journal of Clinical Medicine. 14(18). 6444–6444. 1 indexed citations

Jackowska, Teresa, Iwona Beń‐Skowronek, Łukasz Dembiński, et al.. (2024). Profilaktyka zakażeń syncytialnym wirusem oddechowym (RSV) u dzieci. Rekomendacje Polskiego Towarzystwa Pediatrycznego i Konsultanta krajowego w dziedzinie pediatrii (sierpień 2024 r.). 53(2). 7–27.

Szlagatys‐Sidorkiewicz, Agnieszka, Ewa Bień, Ninela Irga‐Jaworska, et al.. (2024). Managing Undernutrition in Pediatric Oncology: A Consensus Statement Developed Using the Delphi Method by the Polish Society for Clinical Nutrition of Children and the Polish Society of Pediatric Oncology and Hematology. Nutrients. 16(9). 1327–1327. 3 indexed citations

Badowska, Wanda, Agnieszka Mizia‐Malarz, Ewa Bień, et al.. (2024). Rekomendacje zespołu ekspertów dotyczące postępowania z pacjentem z podejrzeniem lub rozpoznaniem nerwiakowłókniakowatości typu 1. 53(3). 41–55.

Czyźewski, K, et al.. (2023). Kinetics of CAR-T cells and immunological profile after tisagenlecleucel therapy. Acta Haematologica Polonica. 54(3). 195–197.

Dębski, Robert, et al.. (2022). Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell Transplantation. Anticancer Research. 42(7). 3607–3612. 26 indexed citations

Cesaro, Simone, Per Ljungman, Małgorzata Mikulska, et al.. (2022). Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 36(6). 1467–1480. 63 indexed citations

10.

Styczyński, Jan, et al.. (2022). Transborder program of allogeneic hematopoietic cell transplantations from unrelated donors for Ukrainian children between 2015–2020 in Bydgoszcz. Acta Haematologica Polonica. 53(6). 407–415.

11.

Snarski, Emilian, Jacqui Stringer, Małgorzata Mikulska, et al.. (2021). Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion—multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT. Bone Marrow Transplantation. 56(12). 2929–2933. 6 indexed citations

12.

Mikulska, Małgorzata, Olaf Penack, Nina Knelange, et al.. (2021). HEV infection in stem cell transplant recipients—retrospective study of EBMT Infectious Diseases Working Party. Bone Marrow Transplantation. 57(2). 167–175. 5 indexed citations

13.

Ljungman, Per, Małgorzata Mikulska, Rafael de la Cámara, et al.. (2020). Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplantation. 56(3). 755–755. 11 indexed citations

14.

Zając‐Spychała, Olga, Agnieszka Zaucha‐Prażmo, Joanna Zawitkowska, et al.. (2020). Infectious complications after hematopoietic stem cell transplantation for primary immunodeficiency in children: A multicenter nationwide study. Pediatric Allergy and Immunology. 31(5). 537–543. 5 indexed citations

15.

Penack, Olaf, Christophe Peczynski, Mohamad Mohty, et al.. (2020). How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Advances. 4(24). 6283–6290. 102 indexed citations

16.

Czyźewski, K, Magdalena Dziedzic, Małgorzata Salamonowicz, et al.. (2019). <p>Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein–Barr Virus Reactivation</p>. Infection and Drug Resistance. Volume 12. 3893–3902. 11 indexed citations

17.

Dziedzic, Magdalena, Iwona Sadowska-Krawczenko, & Jan Styczyński. (2017). Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification. Anticancer Research. 37(12). 6551–6556. 36 indexed citations

18.

Wysocki, Mariusz, et al.. (2006). Complementary and Alternative Medicine in Children with Cancer – Facts and Myths. Advances in Clinical and Experimental Medicine. 15(4). 695–703. 3 indexed citations

19.

Olszewska−Słonina, Dorota, Jan Styczyński, Tomasz Drewa, & Rafał Czajkowski. (2006). Stem Cells – Sources and Plasticity. Advances in Clinical and Experimental Medicine. 15(3). 497–503.

20.

Styczyński, Jan, et al.. (2005). Calcified fibromatosis of the neck in 4-year old girl: Rapid growth, rapid therapy. International Journal of Pediatric Otorhinolaryngology. 69(6). 847–852. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact